On the deal, Linklaters and Kirkland & Ellis advised Novo Holdings; Goodwin advised TA Associates. Novo Holdings, a holding and investment company responsible for managing the...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Bristol Myers Squibb on the deal, and Goodwin Procter advised 2seventy bio. Bristol Myers Squibb (NYSE: BMY) (“BMS”) announced its merger agreement...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the Special Committee of Zuora and Freshfields US advised Zuora, Simpson Thacher & Bartlett advised Silver Lake, Dechert advised GIC, Sullivan & Cromwell...
You must be a Standard 1 Year member to access this content.
Goodwin advised TA Associates alongside Five Arrows in connection with the equity and debt financing of their strategic growth investment in Agilio Software. Agilio Software, a...
You must be a Standard 1 Year member to access this content.
Goodwin advised Renesas Electronics Corporation on the acquisition of Transphorm, assisted by Wilson Sonsini Goodrich & Rosati. On January 11, 2024, Renesas Electronics Corporation (Renesas, TSE:...
You must be a Standard 1 Year member to access this content.
Goodwin advised Renesas Electronics Corporation, and Orrick advised Sequans. Renesas Electronics Corporation (TSE: 6723) and Sequans Communications S.A. (NYSE: SQNS) announced that the two companies have entered...
You must be a Standard 1 Year member to access this content.
Goodwin advised Pulsic on the sale. Cadence Design Systems, Inc. (NasdaqGS:CDNS) completed the acquisition of Pulsic Limited on May 22, 2023. The addition of Pulsic further strengthens...
You must be a Standard 1 Year member to access this content.
Goodwin advised TowerBrook on the deal. TowerBrook Capital Partners (“TowerBrook”) announced its acquisition of a majority stake in Envevo, a UK-based provider of EV design and...
You must be a Standard 1 Year member to access this content.
Goodwin advised TowerBrook on the deal. TowerBrook Capital Partners (“TowerBrook”) announced its acquisition of a majority stake in TXO, a provider of telecom network hardware and asset...
You must be a Standard 1 Year member to access this content.
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised QuadReal Property Group, and Goodwin Procter advised TowerBrook Capital Partners on the deal. QuadReal Property is investing in UK real estate development...
You must be a Standard 1 Year member to access this content.
Goodwin advised Imprivata Inc. on the deal. CMS advised the majority shareholders of Ogitix Software. Imprivata, the digital identity company for mission- and life-critical industries, announced...
You must be a Standard 1 Year member to access this content.
